Ligand Pharmaceuticals participates in three investor conferences

LGND•2026-10-27

Ligand Pharmaceuticals management will meet investors at three healthcare and biotech conferences in November 2026, including a Nov. 10 fireside chat in New York.

1. November conferences

Ligand Pharmaceuticals management will hold investor meetings at the UBS Global Healthcare Conference in Palm Beach Gardens on Nov. 9 and the Miami Biotech Collective Summit in Miami on Nov. 30. A fireside chat at the Stifel 2026 Healthcare Conference is scheduled for Nov. 10 at 10:40 a.m. ET in New York.

Ligand Pharmaceuticals participates in three investor conferences

1. November conferences

Related News

AI wave lifts all boats

Forge Nano Holdings publishes pro forma combined financial statements following ATII merger

Rapport Therapeutics launches $150 million convertible senior notes offering

Conexeu Sciences offers new warrants to encourage early exercise of up to 4,762,780 warrants

First Guaranty Bancshares declares quarterly dividend of $16.875 per Series A preferred share